Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs JPMorgan Ultra Short Income ETF (JPST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs JPMorgan Ultra Short Income ETF — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69.47 (market cap $30.93B), while JPMorgan Ultra Short Income ETF trades at $50.31 (market cap $42.48B). The key difference: JPMorgan Ultra Short Income ETF is the larger of the two by market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while JPMorgan Ultra Short Income ETF pays none. Which is the better fit depends on your goals.
| GEHC | JPST | |
|---|---|---|
Market Cap | $30.93B | $42.48B |
Volume | 5,033,451 | 12,289,471 |
Sector | Health | Fixed Income |
52-Week High | $88.16 | $50.78 |
52-Week Low | $59.48 | $50.22 |
Enterprise Value | $39.39B | — |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 47 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
JPST trades at $50.31, up 0.04% on the day, with a bearish technical signal from moving averages and a neutral stance from oscillators. The ETF maintains consistent dividend distributions of $0.17 per share, with recent payouts in August, September, and October 2026. Short interest decreased significantly by 81.8% in September 2026, indicating reduced bearish bets, while institutional activity shows mixed adjustments with some trimming and others increasing stakes.
The outlook for JPST is cautious amid a bearish technical backdrop and mixed institutional sentiment. Opportunities lie in its role as a cash alternative with steady dividends, but risks include underperformance versus peers and sensitivity to interest rate changes. Investors should weigh its safety appeal against potential yield lag in a rising rate environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About JPMorgan Ultra Short Income ETF
JPST is an actively managed ETF that invests in short-term, investment-grade fixed income securities. It aims to provide current income and capital preservation while maintaining high liquidity.
Read more on JPST →
